3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer

Summary

Phase II trial to study the effectiveness of combining 3-AP with gemcitabine in treating patients who have refractory metastatic breast cancer. Drugs used in chemotherapy, such as 3-AP and gemcitabine, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining 3-AP with gemcitabine may kill more tumor cells

Timeline

Start

2004-10

Primary completion

2006-06

Completion

—

Outcome

Outcome not reported

Stopped: “Administratively complete.”

Drugs

Indications